To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Bentiromide
Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996.) Data
See also
|
||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bentiromide". A list of authors is available in Wikipedia. |
- A new design for an easily fabricated, flexible and wearable white-light LED
- Plasma technology for solvent-free utility wood - ttz Bremerhaven is evaluating the effectiveness of the process with a genetic detection method
- New method for record-breaking polymer membranes - Fivefold increase in performance through gentle treatment
- LyondellBasell’s U.S. Operations and one of its European Holding Companies File Chapter 11 to Restructure Balance Sheet - Company Has Commitment for Significant DIP Financing Including $3.25 Billion of New Funding
- How sweet can you get? - Plant-derived sweetener thaumatin becomes 1.7 times sweeter after amino acid swap